comparemela.com

Latest Breaking News On - Chris dimitropoulos - Page 2 : comparemela.com

Apnimed Secures Funding for Phase 3 Trials of Sleep Apnea Drug Candidate AD109

Apnimed can now move forward with planned phase 3 clinical trials of its AD109 drug candidate for obstructive sleep apnea after it secured $79.75 million in additional financing from investors.

COUR Pharmaceuticals Announces $30M Financing Led by Alpha Wave Ventures

vimarsana © 2020. All Rights Reserved.